Clinical Trial
Published on 31 Mar 2025
Effect of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on ventricular repolarization electrocardiographic parameters in type 2 diabetes patients: DAPA - ECG study
in Diabetes Cardiovascular Complications
- 402 views